Patient presented for application of a Kerecis Omega3 fish skin graft.  The patient's wound, consistent with the documented diagnosis of [Insert specific wound diagnosis e.g., diabetic foot ulcer, venous stasis ulcer, burn wound, traumatic wound, surgical wound], was assessed prior to application.  Measurements of the wound were [length] x [width] x [depth] cm.  The wound bed was characterized as [e.g., granulating, sloughy, necrotic] with [e.g., minimal, moderate, heavy] exudate.  Surrounding skin was [e.g., intact, macerated, erythematous].  The Kerecis graft, sized [dimensions of graft], was prepared per manufacturer instructions and applied directly to the wound bed.  The graft was secured with [e.g., non-adhesive dressing, sterile gauze, surgical staples].  Post-application assessment revealed good graft adherence.  Patient tolerated the procedure well.  Plan includes continued wound care with [frequency] dressing changes using [dressing type] and close monitoring for signs of infection, dehiscence, or other complications.  Patient education provided regarding wound care and signs and symptoms to report.  Follow-up appointment scheduled in [duration] for wound assessment and potential Kerecis graft reapplication.  ICD-10 code [Insert appropriate ICD-10 code for underlying wound and reason for grafting] and CPT code [Insert appropriate CPT codes for wound debridement if performed and application of biological skin substitute] were used for billing purposes. This documentation reflects medical necessity for Kerecis Omega3 wound graft application and supports the treatment plan.